...
机译:纤溶酶原激活物抑制剂调节细胞通过uPAR-dependent粘附机制。
Albany Medical College, Center for Cell Biology & Cancer Research, 47 New Scotland Avenue, Albany, NY 12208, USA. czekayr;
Internalization; CD87 Antigen; Extracellular MatrixUrokinase-Type Plasminogen ActivatorCell AdhesionPlasminogen InactivatorsIntegrinsPlasminogen Activator Inhibitor 1;
机译:Plasminogen-induced PANC-1细胞的聚集血纤维蛋白溶酶,抑制需要转换内源性纤溶酶原激活物inhibitor-1。
机译:Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspases; Catechin; Cell Line, Tumor; Ceramides; Drug Synergism; Enzyme Activation; Humans; Ibuprofen; Male; Mitogen-Activated Protein Kinases; Oxidative Stress; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53;*脱噬作用; Caspase类; 儿茶素; 神经酰胺类; 药物协同作用; 酶激活; 布洛芬; 氧化性应激; 磷酰化; 前列腺肿瘤; 原致癌基因蛋白质 c-bcl-2
机译:临床和形态学特点细胞外Signal-Regulated激酶Inhibitor-Associated视网膜病变
机译:PAI-1(Plasminogen Activator抑制剂-1)表达使蛋白水解地激活的人类巨噬细胞处于静止状态。
机译:蛋白C抑制剂(plasminogen activator inhibitor-3)和静脉血栓形成的风险